IN2014DN06817A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN06817A IN2014DN06817A IN6817DEN2014A IN2014DN06817A IN 2014DN06817 A IN2014DN06817 A IN 2014DN06817A IN 6817DEN2014 A IN6817DEN2014 A IN 6817DEN2014A IN 2014DN06817 A IN2014DN06817 A IN 2014DN06817A
- Authority
- IN
- India
- Prior art keywords
- support member
- macropores
- biologies
- delivery
- certain embodiments
- Prior art date
Links
- 239000002131 composite material Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261588312P | 2012-01-19 | 2012-01-19 | |
| PCT/US2013/022057 WO2013109825A1 (en) | 2012-01-19 | 2013-01-18 | Chromatographic media for storage and delivery of therapeutic biologics and small molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06817A true IN2014DN06817A (enExample) | 2015-05-22 |
Family
ID=48797397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6817DEN2014 IN2014DN06817A (enExample) | 2012-01-19 | 2013-01-18 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20130189322A1 (enExample) |
| EP (1) | EP2804634B1 (enExample) |
| JP (2) | JP6552822B2 (enExample) |
| KR (1) | KR102113296B1 (enExample) |
| AU (1) | AU2013209620B2 (enExample) |
| CA (2) | CA3124806C (enExample) |
| DK (1) | DK2804634T3 (enExample) |
| ES (1) | ES2750211T3 (enExample) |
| IN (1) | IN2014DN06817A (enExample) |
| WO (1) | WO2013109825A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY178616A (en) | 2012-09-17 | 2020-10-19 | Grace W R & Co | Chromatography media and devices |
| EP3024843B1 (en) | 2013-07-25 | 2022-08-31 | Bio-Rad Laboratories, Inc. | Enhanced functionality and delivery of a protein from a porous substrate |
| FR3012978A1 (fr) * | 2013-11-12 | 2015-05-15 | Biocarecell | Filtre biocompatible et procede de fabrication d'un filtre biocompatible. |
| SG11201605712SA (en) | 2014-01-16 | 2016-08-30 | Grace W R & Co | Affinity chromatography media and chromatography devices |
| CN107847907A (zh) | 2014-05-02 | 2018-03-27 | 格雷斯公司 | 官能化载体材料以及制备和使用官能化载体材料的方法 |
| IS3008B (is) * | 2014-05-14 | 2018-12-15 | Calor ehf | Stöðgandi lausnir fyrir prótín og peptíð |
| BR112017026193B1 (pt) | 2015-06-05 | 2021-09-14 | W.R. Grace & Co-Conn | Adsorventes, método de produção dos adsorventes e uso dos adsorventes |
| AU2019254473A1 (en) * | 2018-04-16 | 2020-12-03 | Merck Patent Gmbh | Additives for protein formulations to improve thermal stability |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059654A (en) * | 1983-02-14 | 1991-10-22 | Cuno Inc. | Affinity matrices of modified polysaccharide supports |
| DE229810T1 (de) * | 1985-07-09 | 1987-11-05 | Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire | Beschuetzung von proteinen und aehnlichem. |
| WO1992008790A1 (en) * | 1990-11-14 | 1992-05-29 | Cargill, Incorporated | Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
| US5159049A (en) * | 1991-04-22 | 1992-10-27 | Allen Robert C | Method for stabilizing polyacrylamide gels |
| US5583162A (en) * | 1994-06-06 | 1996-12-10 | Biopore Corporation | Polymeric microbeads and method of preparation |
| US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
| SE9904475D0 (sv) * | 1999-12-08 | 1999-12-08 | Artursson | Nucleic acid delivery system |
| US6896894B2 (en) * | 2001-10-30 | 2005-05-24 | Battelle Memorial Institute | Proteins stabilized with polysaccharide gums |
| CA2474698C (en) * | 2002-02-08 | 2009-07-21 | Alkermes Controlled Therapeutics, Inc. | Polymer-based compositions for sustained release |
| US20040137004A1 (en) * | 2002-03-19 | 2004-07-15 | Glenn Gregory M | Patch for transcutaneous immunization |
| US6666281B2 (en) | 2002-03-19 | 2003-12-23 | Deere & Company | Bearing guard for a ground-working implement |
| EP2143481A1 (en) | 2003-02-19 | 2010-01-13 | Natrix Separations Inc. | Composite materials comprising supported porous gels |
| US7785769B2 (en) * | 2003-07-25 | 2010-08-31 | The United States of America as reprsented by the Secretary of the Navy | Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| US8182694B2 (en) | 2004-04-08 | 2012-05-22 | Natrix Separations Inc. | Membrane stacks |
| EP1758937B1 (en) * | 2004-05-24 | 2009-09-02 | Genvault Corporation | Stable protein storage and stable nucleic acid storage in recoverable form |
| AU2005251838B2 (en) * | 2004-06-07 | 2011-04-21 | Merck Millipore Ltd. | Stable composite material comprising supported porous gels |
-
2013
- 2013-01-18 ES ES13739077T patent/ES2750211T3/es active Active
- 2013-01-18 KR KR1020147022518A patent/KR102113296B1/ko active Active
- 2013-01-18 CA CA3124806A patent/CA3124806C/en active Active
- 2013-01-18 EP EP13739077.9A patent/EP2804634B1/en active Active
- 2013-01-18 IN IN6817DEN2014 patent/IN2014DN06817A/en unknown
- 2013-01-18 CA CA2861932A patent/CA2861932C/en active Active
- 2013-01-18 AU AU2013209620A patent/AU2013209620B2/en active Active
- 2013-01-18 WO PCT/US2013/022057 patent/WO2013109825A1/en not_active Ceased
- 2013-01-18 DK DK13739077T patent/DK2804634T3/da active
- 2013-01-18 US US13/744,583 patent/US20130189322A1/en not_active Abandoned
- 2013-01-18 JP JP2014553432A patent/JP6552822B2/ja active Active
-
2018
- 2018-09-20 JP JP2018175774A patent/JP2019011341A/ja active Pending
-
2019
- 2019-09-04 US US16/560,370 patent/US20200069602A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR102113296B1 (ko) | 2020-06-02 |
| US20130189322A1 (en) | 2013-07-25 |
| ES2750211T3 (es) | 2020-03-25 |
| AU2013209620B2 (en) | 2017-06-15 |
| KR20140117529A (ko) | 2014-10-07 |
| JP6552822B2 (ja) | 2019-07-31 |
| CA3124806C (en) | 2023-09-26 |
| CA2861932C (en) | 2021-09-14 |
| AU2013209620A1 (en) | 2014-08-28 |
| CA2861932A1 (en) | 2013-07-27 |
| JP2015504092A (ja) | 2015-02-05 |
| EP2804634B1 (en) | 2019-08-28 |
| EP2804634A4 (en) | 2015-07-22 |
| DK2804634T3 (da) | 2019-11-04 |
| US20200069602A1 (en) | 2020-03-05 |
| WO2013109825A1 (en) | 2013-07-25 |
| CA3124806A1 (en) | 2013-07-27 |
| EP2804634A1 (en) | 2014-11-26 |
| JP2019011341A (ja) | 2019-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN06817A (enExample) | ||
| ZA201505813B (en) | Biologically active molecules, conjugates thereof, and therapeutic uses | |
| PH12019550145A1 (en) | Physiologically active substance carrier | |
| MD20160079A2 (ro) | Sistem de livrare a medicamentului | |
| MX2015001083A (es) | Polipeptidos de factor x modificados y usos de los mismos. | |
| DK2925272T3 (da) | Lægemiddelopbevarings-, udleverings- og administrationssystem | |
| MX2016014622A (es) | Sistemas de suministro de medicamentos y metodos de uso relacionados. | |
| IL238476A0 (en) | il-15r forms, cells expressing 15r-il forms and therapeutic uses of 15r-il alpha and 15r-il/15-il alpha complexes | |
| MY156697A (en) | Modified tuberculosis antigens | |
| WO2013028942A8 (en) | Targeting microbubbles | |
| FI20116138A7 (fi) | Matriisi bioaktiivisten aineiden hallittuun vapauttamiseen | |
| SG11201502455TA (en) | Fgfr3 fusion gene and pharmaceutical drug targeting same | |
| WO2013177231A8 (en) | Translocation of non-natural chemical entities through anthrax protective antigen pore | |
| PH12015502166A1 (en) | Extracorporeal life support system and methods of use thereof | |
| IL243081B (en) | A hospital unit for storing patients, a patient transport system, and a life-saving patient transport system | |
| IL226205B (en) | Fusion proteins, pharmaceutical preparations containing them and their use in the preparation of drugs for the treatment of cancer | |
| MX2017003638A (es) | Microparticulas inyectables para liberacion hiper-localizada de agentes terapeuticos. | |
| ZA201409367B (en) | A method to produce a medicinal product comprising a biologically active protein and the resulting product | |
| EP2968248A4 (en) | TRANSDERMAL ACTIVE COMPOSITION SYSTEM WITH RIVASTIGMIN | |
| WO2013016578A3 (en) | Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers | |
| MX2014012164A (es) | Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica. | |
| SI2921166T1 (sl) | Biološko razgradljive mikro kroglice z izboljšano adsorpcijo antikance rogenih zdravil, ki vsebujejo albumin in dekstran sulfat, ter postopek za njihovo pripravo | |
| EP3330379A4 (en) | Aptamer against insulin receptor and pharmaceutical composition containing the same | |
| MX350159B (es) | Inyecciones mejoradas. | |
| EP2898944A4 (en) | ADSORPTION PROCEDURE, ADSORPTION / SEPARATION PROCEDURE AND MEDICAMENT CARRIER CARRIER |